Elucidating the effects of mTOR inhibitors from Malaysian natural products on tuberous sclerosis complex cell line

Mammalian target of rapamycin (mTOR) inhibitors are a highly recommended first-line therapy for tuberous sclerosis complex (TSC)-associated angiomyolipoma. Everolimus has been approved by the United States Food and Drug Administration (USFDA) for treatment of TSC-related angiomyolipoma that do no...

Full description

Saved in:
Bibliographic Details
Main Author: Zulkipli, Ninie Nadia
Format: Thesis
Language:English
Published: 2022
Subjects:
Online Access:http://eprints.usm.my/53406/1/NINIE%20NADIA%20BINTI%20ZULKIPLI-FINAL%20THESIS%20P-UD001418%28R%29%20PWD_-24%20pages.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items